(ARRY) Array Biopharma complete technical analysis [charts+indicators] | Buy/Sell Array Biopharma | (ARRY) share price targets
Complete technical analysis of Array Biopharma (ARRY) by charts plus indicators, forecast predictions and share price targets for Array Biopharma (ARRY)
Array Biopharma trades in USA in Health Care sector.
Showing technical analysis as on 2024-06-27 View latest technical analysis
10 day averaged volume of Array Biopharma is 4325400
| Date | Daily Closing Price | Open | High | Low | Volume |
| 27 Thu Jun 2024 | 10.60 | 10.44 | 10.68 | 10.23 | 0.92 times |
| 26 Wed Jun 2024 | 10.39 | 10.61 | 10.71 | 10.25 | 0.869 times |
| 25 Tue Jun 2024 | 10.71 | 10.92 | 10.96 | 10.54 | 1.413 times |
| 24 Mon Jun 2024 | 10.96 | 11.21 | 11.46 | 10.92 | 1.146 times |
| 21 Fri Jun 2024 | 11.29 | 12.25 | 12.27 | 11.11 | 1.898 times |
| 20 Thu Jun 2024 | 12.33 | 12.52 | 12.62 | 12.15 | 0.677 times |
| 18 Tue Jun 2024 | 12.82 | 12.27 | 12.83 | 12.22 | 0.683 times |
| 18 Tue Jun 2024 | 12.82 | 12.27 | 12.83 | 12.22 | 0.683 times |
| 17 Mon Jun 2024 | 12.40 | 12.38 | 12.67 | 12.10 | 0.711 times |
| 14 Fri Jun 2024 | 12.42 | 12.93 | 13.01 | 12.39 | 0.675 times |
My analysis of stock is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if stock stays below 11.4, but if it comes above 11.4, then a intra day buy could be more profitable.
If you take a sell trade below 11.4, then use 11.4 as stoploss and 10 as target. However if you take a buy trade in stock , then use 11.4 as stoploss and 12.63 as target.
Share price targets for Array Biopharma (ARRY)
| Target Type | Value |
| Downside Target | 10.23 |
| Downside Target | 10.60 |
| Upside Target | 10.82 |
| Upside Target | 11.11 |
| Upside Target | 11.38 |
| Upside Target | 12.10 |
| Upside Target | 12.81 |
| Upside Target | 13.13 |
| Upside Target | 14.27 |
| Upside Target | 14.45 |
| Upside Target | 14.85 |
| Upside Target | 15.12 |
| Upside Target | 15.35 |
| Upside Target | 16.22 |
Intraday share price targets for Array Biopharma (ARRY)
| Target Type | Value |
| Downside Intraday Target | 10.07 |
| Downside Intraday Target | 9.53 |
| Upside Intraday Target | 11.3 |
| Upside Intraday Target | 11.99 |
| Upside Intraday Target | 10.76 |
Weekly technical analysis of Array Biopharma (ARRY)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 27 Thu Jun 2024 | 10.60 | 11.21 | 11.46 | 10.23 | 1.334 times |
| 21 Fri Jun 2024 | 11.29 | 12.27 | 12.83 | 11.11 | 2.339 times |
| 18 Tue Jun 2024 | 12.82 | 12.38 | 12.83 | 12.10 | 0.21 times |
| 14 Fri Jun 2024 | 12.42 | 13.14 | 14.27 | 12.28 | 1.856 times |
| 07 Fri Jun 2024 | 13.44 | 14.12 | 14.45 | 13.13 | 0.881 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Array Biopharma (ARRY)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 27 Thu Jun 2024 | 10.60 | 14.12 | 14.45 | 10.23 | 0.603 times |
| 31 Fri May 2024 | 14.18 | 12.38 | 14.85 | 10.60 | 1.222 times |
| 30 Tue Apr 2024 | 12.34 | 15.02 | 15.12 | 10.82 | 0.982 times |
| 28 Thu Mar 2024 | 14.91 | 13.68 | 15.35 | 11.38 | 0.868 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Array Biopharma (ARRY)
Price action analysis of Array Biopharma ( (ARRY) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Array Biopharma ( (ARRY) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Array Biopharma ( (ARRY) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Array Biopharma ( (ARRY) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Array Biopharma stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Array Biopharma in short term and the sell signal is strong.
Array Biopharma Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Array Biopharma in short term but BUY signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Array Biopharma is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 11.47 and Array Biopharma (ARRY) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Array Biopharma (ARRY) stock. Volume based technical analysis of Array Biopharma (ARRY) stock is negative.
Array Biopharma Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Array Biopharma ( (ARRY) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Array Biopharma ( (ARRY) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Array Biopharma ( (ARRY) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Array Biopharma ( (ARRY) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Array Biopharma stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Array Biopharma in short term and the sell signal is strong.
Array Biopharma Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Array Biopharma in short term but BUY signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Array Biopharma is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 11.47 and Array Biopharma (ARRY) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Array Biopharma (ARRY) stock. Volume based technical analysis of Array Biopharma (ARRY) stock is negative.
Array Biopharma Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.